Page 4 - Kiran Mazumdar-shaw

Kiran Mazumdar-Shaw wins EY Entrepreneur of the Year award for 2019

Awards announced for nine other categories; Adi Godrej gets Lifetime achievement award

Budget 2020: Well-intentioned but could have done better, says BS jury

The Budget is an attempt to endow India with improved health and better access to education unleashing better infrastructure, says Rajnish Kumar

US to lead Biocon Biologics' drive towards $1 billion revenue

The company is uniquely positioned in the US as it is the only Indian pharmaceutical firm with two commercialised biosimilars in the market

Biocon's pre-tax profit rises 9% to Rs 315 crore in Oct-Dec quarter

The consolidated Ebitda margin stood at 27% in Q3FY20.

Tata Sons Chairman N Chandrasekaran joins platform LinkedIn as influencer

Other LinkedIn Influencers from India include Kiran Mazumdar Shaw, Kailash Satyarthi, Vani Kola, and Anny Divya.

Why CMD role separation remains a work in progress despite deadline nearing

Sebi, in its October 2017 report on corporate governance, said listed firms should have a different person heading the management and another in place as chairman of the board

When Rahul Bajaj, Kiran Mazumdar-Shaw broke deafening silence of India Inc

In visible signs of economic woes, the auto sector went through one of the longest sales slumps leading to nearly 3.5 lakh job losses.

Biocon elevates Chief Financial Officer Siddharth Mittal as Joint MD & CEO

Mittal takes over from Arun Chandavarkar, who retired on November 30 after 29 years at Biocon

Siddharth Mittal succeeds Arun Chandavarkar as CEO, Joint MD of Biocon

Bengaluru-headquartered biopharmaceuticals company Biocon Ltd on Tuesday said Siddharth Mittal has taken over as its chief executive officer and joint managing director. "Siddharth Mittal has taken over as Chief Executive Officer & Joint Managing Director of the company starting December 1, 2019," the company said in a BSE filing. Mittal has been serving as Chief Financial Officer (CFO) of Biocon since August 2014, the filing said. Mittal takes over from Arun Chandavarkar who retired as chief executive and joint MD of the company on November 30. "I am very pleased to welcome Siddharth as CEO & Joint MD of Biocon," Biocon CMD Kiran Mazumdar-Shaw said.

India Inc neither 'anti-national nor anti-government': Kiran Mazumdar Shaw

Supporting Bajaj, Shaw had earlier said, 'Hope the govt reaches out to India Inc for working out solutions to revive consumption n growth'

Always better to seek an answer than spreading one's own impression: FM

Kiran Mazumdar- Shaw says India Inc is treated as pariahs

India Inc is a pariah, feels govt dislikes criticism: Kiran Mazumdar Shaw

Shaw's remarks came a day after veteran industrialist Rahul Bajaj said the people were afraid to criticise the government.

GDP shocker: India Inc expects growth to rebound in Q3 on stimulus measures

Biocon CMD Kiran Mazumdar-Shaw opined that few pragmatic policies can help put India on the top again

USFDA approves production of Biocon biosimilar at new Bengaluru unit

The US Food and Drug Administration's (USFDA's) nod to Biocon's supplemental biologics licence application for the new unit will expand the company's capacity multifold, the company said

Kiran Mazumdar Shaw settles 'insider trading case' with Sebi in Infy matter

Accordingly, she filed a settlement application without admitting or denying the default and remitted Rs 3,01,758 in September 2019.

Insulin at Rs 7 will be a gamechanger for us: Biocon's Kiran Mazumdar-Shaw

'We are trying to develop a strategy where we could make people to stop using disposable plastic devices', said Shaw

Biocon posts profit before tax of Rs 354 cr for quarter ended September 30

Excluding the exceptional item, the PBT grew 9 per cent on year-on-year basis

FM versus Biocon chief on Twitter over e-cigarettes settles amicably

Shaw, head of Biocon, had earlier wondered why the finance minister, and not the health minister, addressed the press conference

CEOs bank on festive cheer; India Inc hopes for improvement in second half

Demand to pick up from festival season next month, say corporate leaders

Kiran Mazumdar-Shaw on curing cancer and the perils of a divisive society

Shaw says she tells her pharma colleagues that they are in a humanitarian business - like it or not, patients come first and if patients are the focus, profits would come naturally